Common adverse effects associated with Letzicare 2.5MG encompass hot flashes, fatigue, joint discomfort, and nausea. Although less frequent, more severe side effects may involve bone density reduction (osteoporosis), cardiovascular issues, and significant allergic reactions. It is essential for patients to communicate any atypical symptoms to their healthcare provider. Ongoing monitoring is recommended to effectively manage potential side effects.

When Letrozole is used?

Letrozole is typically administered following surgical procedures to minimize the likelihood of breast cancer recurrence or metastasis.

If you are undergoing chemotherapy or radiotherapy, your healthcare provider will advise you on the optimal timing for initiating letrozole treatment.

In certain instances, letrozole may be utilized as the initial treatment for breast cancer, particularly when surgery is not feasible or must be postponed. It is also sometimes prescribed prior to surgery to reduce the size of a larger tumor.

Additionally, letrozole can be employed in the management of recurrent breast cancer. It is also indicated for cases where breast cancer has metastasized to other regions of the body (secondary breast cancer), often in conjunction with another medication.